The Maltese Diabetes Association (MDA) has urged authorities to clarify the government's intentions beyond the six-month pilot to provide free continuous glucose monitors (CGM)...
Novo Nordisk said Monday that its type 2 diabetes treatment Xultophy showed superior efficacy in reducing hemoglobin A1c (HbA1c) levels, weight change and lower...